Cole F E, Gladden K M, Bennett D J, Erwin D T
Clin Chim Acta. 1984 May 30;139(2):137-43. doi: 10.1016/0009-8981(84)90322-x.
In an attempt to reconcile estimates of plasma oxalate concentration by in vitro and in vivo assays, the in vitro radioenzymatic isotope dilution assay (REIDA) for plasma oxalate concentration was modified by initiating precipitation of calcium oxalate from plasma ultrafiltrates within one hour of phlebotomy. Plasma oxalate concentration form normal males was 4.0 mumol/1, consistent with reported values of 3.0 mumol/1 and 2.3 mumol/1 by enzymatic methods, and 2.8 mumol/1 by a gas chromatographic technique, and lower than 10.0 mumol/1 reported previously by chemical/enzymatic methods. This lower estimate of oxalate results, at least in part, from avoiding in vitro conversion of ultrafilterable substances to oxalate, and from the use of 'fire-cleaned' glassware. No difference in plasma oxalate was observed between age-matched, apparently healthy black and white males or with blood collected in the presence and absence of inhibitors of the conversion of glyoxalate to oxalate.
为了协调通过体外和体内测定法对血浆草酸盐浓度的估计,对血浆草酸盐浓度的体外放射酶同位素稀释测定法(REIDA)进行了改进,方法是在采血后一小时内从血浆超滤液中开始沉淀草酸钙。正常男性的血浆草酸盐浓度为4.0μmol/L,与酶法报告的3.0μmol/L和2.3μmol/L的值以及气相色谱技术报告的2.8μmol/L一致,低于之前化学/酶法报告的10.0μmol/L。草酸盐的这种较低估计结果至少部分是由于避免了可超滤物质在体外转化为草酸盐,以及使用了“火烤清洁”的玻璃器皿。在年龄匹配、表面健康的黑人和白人男性之间,以及在有无乙醛酸转化为草酸盐的抑制剂存在的情况下采集的血液之间,未观察到血浆草酸盐有差异。